Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
051905.KS Stock Summary
Top 10 Correlated ETFs
051905.KS
In the News
051905.KS Financial details
Company Rating
Sell
Market Cap
5720.32B
Income
142.76B
Revenue
6804.84B
Book val./share
324268.13
Cash/share
55325.59
Dividend
4050
Dividend %
2.74%
Employees
4.4K
Optionable
No
Shortable
Yes
Earnings
25 Apr 2024
P/E
15.88
Forward P/E
-
PEG
-4
P/S
0.72
P/B
0.45
P/C
3.14
P/FCF
7.46
Quick Ratio
1.38
Current Ratio
2.08
Debt / Equity
0.04
LT Debt / Equity
0
-
-
EPS (TTM)
8.52K
EPS next Y
-
EPS next Q
-
EPS this Y
-39.65%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-28.76%
Revenue last 5Y
-2.4%
Revenue Q/Q
-10.25%
EPS Q/Q
-245.01%
-
-
-
-
SMA20
9.53%
SMA50
22.1%
SMA100
15.06%
Inst Own
-
Inst Trans
-
ROA
2%
ROE
3%
ROC
0.09%
Gross Margin
54%
Oper. Margin
8%
Profit Margin
2%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
134600.0-285000.0
52W High
-39.12%
52W Low
+28.9%
RSI
55
Rel Volume
0.91
Avg Volume
7.71K
Volume
7.03K
Perf Week
1.82%
Perf Month
10.58%
Perf Quarter
7.76%
Perf Half Y
5.22%
-
-
-
-
Beta
0.957
-
-
Volatility
2228.3%, 7396.83%
Prev Close
2.48%
Price
173500
Change
1.46%
051905.KS Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-12-31
Metric | History | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 458.67K | 468.16K | 482.9K | 428.85K | 406.11K | |
Net income per share | 46.44K | 47.6K | 50.4K | 14.12K | 8.52K | |
Operating cash flow per share | 68.01K | 59.97K | 58.75K | 29.68K | 39.33K | |
Free cash flow per share | 48.02K | 29K | 38.93K | 19.75K | 29.57K | |
Cash per share | 42.93K | 29.4K | 49.53K | 40.41K | 55.33K | |
Book value per share | 247.48K | 283.84K | 321.56K | 318.65K | 324.27K | |
Tangible book value per share | 146.2K | 166.25K | 198.68K | 201.02K | 211.33K | |
Share holders equity per share | 247.48K | 283.84K | 321.56K | 318.65K | 324.27K | |
Interest debt per share | 42.68K | 28.73K | 31.89K | 27.32K | 13.81K | |
Market cap | 12918.91B | 12030.84B | 10321.72B | 5194.37B | 2640.75B | |
Enterprise value | 12973.05B | 12065.62B | 10108.96B | 4982.17B | 2077.12B | |
P/E ratio | 16.6 | 15.08 | 12.22 | 21.96 | 18.5 | |
Price to sales ratio | 1.68 | 1.53 | 1.28 | 0.72 | 0.39 | |
POCF ratio | 11.34 | 11.97 | 10.48 | 10.45 | 4.01 | |
PFCF ratio | 16.06 | 24.76 | 15.82 | 15.7 | 5.33 | |
P/B Ratio | 3.12 | 2.53 | 1.92 | 0.97 | 0.49 | |
PTB ratio | 3.12 | 2.53 | 1.92 | 0.97 | 0.49 | |
EV to sales | 1.69 | 1.54 | 1.25 | 0.69 | 0.31 | |
Enterprise value over EBITDA | 8.92 | 8.14 | 6.39 | 5.07 | 2.74 | |
EV to operating cash flow | 11.38 | 12.01 | 10.27 | 10.02 | 3.15 | |
EV to free cash flow | 16.12 | 24.83 | 15.5 | 15.06 | 4.19 | |
Earnings yield | 0.06 | 0.07 | 0.08 | 0.05 | 0.05 | |
Free cash flow yield | 0.06 | 0.04 | 0.06 | 0.06 | 0.19 | |
Debt to equity | 0.17 | 0.1 | 0.1 | 0.08 | 0.04 | |
Debt to assets | 0.11 | 0.07 | 0.07 | 0.06 | 0.03 | |
Net debt to EBITDA | 0.04 | 0.02 | -0.13 | -0.22 | -0.74 | |
Current ratio | 1.22 | 1.34 | 1.62 | 1.96 | 2.23 | |
Interest coverage | 84.82 | 97.61 | 102.87 | 47.95 | 24.74 | |
Income quality | 1.45 | 1.24 | 1.14 | 1.92 | 4.62 | |
Dividend Yield | 0.01 | 0.02 | 0.02 | 0.04 | 0.04 | |
Payout ratio | 0.2 | 0.25 | 0.22 | 0.85 | 0.68 | |
Sales general and administrative to revenue | 0.02 | 0.01 | 0.01 | 0.02 | 0.02 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0.01 | |
Intangibles to total assets | 0.28 | 0.3 | 0.29 | 0.29 | 0.28 | |
Capex to operating cash flow | -0.29 | -0.52 | -0.34 | -0.33 | -0.25 | |
Capex to revenue | -0.04 | -0.07 | -0.04 | -0.02 | -0.02 | |
Capex to depreciation | -1.33 | -1.98 | -1.21 | -0.58 | -0.61 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 508.5K | 551.37K | 603.86K | 318.16K | 249.32K | |
ROIC | 0.17 | 0.16 | 0.15 | 0.07 | 0.05 | |
Return on tangible assets | 0.17 | 0.17 | 0.16 | 0.05 | 0.03 | |
Graham Net | -38.39K | -32.61K | -14.76K | -11.53K | 7.68K | |
Working capital | 391.87B | 503.05B | 947.04B | 1121.63B | 1339.92B | |
Tangible asset value | 2449.77B | 2785.75B | 3329.11B | 3368.25B | 3541.05B | |
Net current asset value | -93.51B | 30.55B | 415.48B | 450.29B | 758.22B | |
Invested capital | 0.17 | 0.1 | 0.1 | 0.08 | 0.04 | |
Average receivables | 678.16B | 686.39B | 659.11B | 643.98B | 611.24B | |
Average payables | 253.13B | 270.93B | 260.88B | 241.88B | 233.29B | |
Average inventory | 680.54B | 777.64B | 904.81B | 978.04B | 919.97B | |
Days sales outstanding | 32.98 | 31.56 | 28.87 | 32.92 | 30.81 | |
Days payables outstanding | 36.37 | 30.94 | 32.49 | 24.56 | 27.85 | |
Days of inventory on hand | 93.38 | 99.66 | 120.15 | 110.06 | 97.21 | |
Receivables turnover | 11.07 | 11.56 | 12.65 | 11.09 | 11.85 | |
Payables turnover | 10.04 | 11.8 | 11.24 | 14.86 | 13.11 | |
Inventory turnover | 3.91 | 3.66 | 3.04 | 3.32 | 3.75 | |
ROE | 0.19 | 0.17 | 0.16 | 0.04 | 0.03 | |
Capex per share | -20K | -30.97K | -19.82K | -9.93K | -9.76K |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q4
Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 107.89K | 100.48K | 107.88K | 104.21K | 93.53K | |
Net income per share | -6.49K | 5.45K | 5.33K | 5.03K | -7.29K | |
Operating cash flow per share | 18.91K | 7.95K | 15.61K | 7.59K | 8.18K | |
Free cash flow per share | 16.6K | 5.87K | 13.2K | 4.67K | 5.83K | |
Cash per share | 40.41K | 47.81K | 53.33K | 55.49K | 55.33K | |
Book value per share | 318.65K | 322.44K | 324.05K | 329.43K | 324.27K | |
Tangible book value per share | 201.02K | 201.81K | 206.3K | 210.79K | 211.33K | |
Share holders equity per share | 318.65K | 322.44K | 324.05K | 329.43K | 324.27K | |
Interest debt per share | 26.69K | 29.58K | 27.42K | 24.53K | 12.91K | |
Market cap | 5194.37B | 4147.12B | 3141.76B | 2922.25B | 2640.75B | |
Enterprise value | 4982.17B | 3842.04B | 2719.31B | 2414.71B | 2077.12B | |
P/E ratio | -11.94 | 11.34 | 8.8 | 8.68 | -5.41 | |
Price to sales ratio | 2.87 | 2.46 | 1.74 | 1.67 | 1.68 | |
POCF ratio | 16.39 | 31.13 | 12.01 | 22.99 | 19.26 | |
PFCF ratio | 18.67 | 42.15 | 14.21 | 37.32 | 27.04 | |
P/B Ratio | 0.97 | 0.77 | 0.58 | 0.53 | 0.49 | |
PTB ratio | 0.97 | 0.77 | 0.58 | 0.53 | 0.49 | |
EV to sales | 2.76 | 2.28 | 1.5 | 1.38 | 1.33 | |
Enterprise value over EBITDA | 25.3 | 4.25 | 2.75 | 11.6 | 17.05 | |
EV to operating cash flow | 15.72 | 28.84 | 10.4 | 19 | 15.15 | |
EV to free cash flow | 17.91 | 39.05 | 12.3 | 30.83 | 21.27 | |
Earnings yield | -0.02 | 0.02 | 0.03 | 0.03 | -0.05 | |
Free cash flow yield | 0.05 | 0.02 | 0.07 | 0.03 | 0.04 | |
Debt to equity | 0.08 | 0.09 | 0.08 | 0.07 | 0.04 | |
Debt to assets | 0.06 | 0.06 | 0.06 | 0.05 | 0.03 | |
Net debt to EBITDA | -1.08 | -0.34 | -0.43 | -2.44 | -4.63 | |
Current ratio | 1.96 | 1.92 | 2 | 2.08 | 2.23 | |
Interest coverage | 29.24 | 7.09 | 32.56 | 24.66 | 11.93 | |
Income quality | -2.91 | 1.38 | 2.71 | 1.39 | -1.12 | |
Dividend Yield | 0 | 0 | 0.03 | 0 | 0 | |
Payout ratio | 0 | 0 | 1.09 | 0 | 0 | |
Sales general and administrative to revenue | 0.02 | 0.45 | 0.46 | 0.02 | 0.02 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0.01 | |
Intangibles to total assets | 0.29 | 0.28 | 0.28 | 0.28 | 0.28 | |
Capex to operating cash flow | -0.12 | -0.26 | -0.15 | -0.38 | -0.29 | |
Capex to revenue | -0.02 | -0.02 | -0.02 | -0.03 | -0.03 | |
Capex to depreciation | -0.53 | -0.5 | -0.59 | -0.75 | -0.59 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 215.76K | 198.93K | 197.07K | 193K | 230.58K | |
ROIC | 0.02 | 0.02 | 0.02 | 0.02 | 0.01 | |
Return on tangible assets | -0.02 | 0.02 | 0.02 | 0.02 | -0.02 | |
Graham Net | -11.53K | -9.72K | -2.11K | 3K | 7.68K | |
Working capital | 1121.63B | 1184.77B | 1260.8B | 1369.86B | 1339.92B | |
Tangible asset value | 3368.25B | 3381.55B | 3456.83B | 3532B | 3541.05B | |
Net current asset value | 450.29B | 494.57B | 598.22B | 704.18B | 758.22B | |
Invested capital | 0.08 | 0.09 | 0.08 | 0.07 | 0.04 | |
Average receivables | 742.16B | 686.5B | 726.49B | 772.23B | 695.42B | |
Average payables | 223.86B | 237.96B | 262.51B | 267.75B | 263.31B | |
Average inventory | 1010.1B | 951.37B | 922.54B | 889.98B | 883.35B | |
Days sales outstanding | 32.26 | 38.75 | 36.25 | 42.08 | 32.99 | |
Days payables outstanding | 23.9 | 30.36 | 28.79 | 29.85 | 28.77 | |
Days of inventory on hand | 107.11 | 109.46 | 98.55 | 96.37 | 100.43 | |
Receivables turnover | 2.79 | 2.32 | 2.48 | 2.14 | 2.73 | |
Payables turnover | 3.77 | 2.96 | 3.13 | 3.02 | 3.13 | |
Inventory turnover | 0.84 | 0.82 | 0.91 | 0.93 | 0.9 | |
ROE | -0.02 | 0.02 | 0.02 | 0.02 | -0.02 | |
Capex per share | -2.31K | -2.08K | -2.41K | -2.91K | -2.36K |
051905.KS Frequently Asked Questions
What is LG Household & Health Care Ltd. stock symbol ?
LG Household & Health Care Ltd. is a KR stock and trading under the symbol 051905.KS
What is LG Household & Health Care Ltd. stock quote today ?
LG Household & Health Care Ltd. stock price is $173500 today.
Is LG Household & Health Care Ltd. stock public?
Yes, LG Household & Health Care Ltd. is a publicly traded company.